Body Composition Is an Independent Predictor of Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib

BACKGROUND: Previous studies have suggested body composition as a predictor of sorafenib toxicity and outcome in patients with advanced hepatocellular carcinoma (HCC). Large studies on the impact of body composition parameters in European HCC patients are lacking. Our aim was to validate the prognos...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Liver Cancer
Main Authors: Labeur, Tim A., van Vugt, Jeroen L.A., Ten Cate, David W.G., Takkenberg, R. Bart, IJzermans, Jan N.M., Groot Koerkamp, Bas, de Man, Robert A., van Delden, Otto M., Eskens, Ferry A.L.M., Klümpen, Heinz-Josef
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2019
Teme:
Original Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738194/
https://ncbi.nlm.nih.gov/pubmed/31602369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493586
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki